Stock comparison
Axogen, Inc. is 2.0x more valuable than CONMED Corp by market capitalization ($2.32 B vs $1.16 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AXGN is larger
Axogen, Inc. is 2.0x more valuable than CONMED Corp by market capitalization ($2.32 B vs $1.16 B).
Market value leader
AXGN
Axogen, Inc. is 2.0x more valuable than CONMED Corp by market capitalization ($2.32 B vs $1.16 B).
Revenue leader
CNMD
CNMD: $1.37B vs AXGN: $225.21M.
Profit leader
CNMD
CNMD: $47.10M vs AXGN: -$15.70M.
Margin leader
CNMD
CNMD: 3.4% vs AXGN: -7.0% net margin.
| Metric | CNMD | AXGN |
|---|---|---|
| Market cap | $1.16 B | $2.32 B |
| US-listed rank | #2547 | #2028 |
| Revenue (latest FY) | $1.37B | $225.21M |
| Net income (latest FY) | $47.10M | -$15.70M |
| Net margin | 3.4% | -7.0% |
| P/E (trailing FY) | 24.6x | - |
| SEC filings | 2,228 | 1,334 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Axogen, Inc. is 2.0x more valuable than CONMED Corp by market capitalization ($2.32 B vs $1.16 B).
In their latest fiscal years, CONMED Corp reported $1.37B in revenue while Axogen, Inc. reported $225.21M.
Full pages: CONMED Corp and Axogen, Inc., or browse the full rankings.